Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000210520 | SCV000266805 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000437200 | SCV000518961 | benign | not specified | 2018-01-19 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000562445 | SCV000664459 | likely benign | Hereditary cancer-predisposing syndrome | 2014-07-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Illumina Laboratory Services, |
RCV001152356 | SCV001313570 | benign | Hereditary pheochromocytoma-paraganglioma | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV001152357 | SCV001313571 | uncertain significance | Leigh syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001157834 | SCV001319439 | uncertain significance | Mitochondrial complex II deficiency, nuclear type 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000437200 | SCV002046734 | benign | not specified | 2021-03-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000437200 | SCV002069749 | benign | not specified | 2021-12-30 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316168 | SCV004015387 | benign | Paragangliomas 5 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001579483 | SCV004151957 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | SDHA: BP4, BP7 |
Prevention |
RCV003977580 | SCV004787155 | benign | SDHA-related condition | 2019-03-20 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV001579483 | SCV001807428 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001579483 | SCV001951777 | likely benign | not provided | no assertion criteria provided | clinical testing |